Author:
Alfahl Zina,Einarsson Gisli,Elborn Stuart,Gilpin Deirdre F.,O’Neill Katherine,Ferguson Kathryn,Hill Adam T.,Loebinger Michael,Carroll Mary,Gatheral Timothy,De Soyza Anthony,Chalmers James D.,Johnson Christopher,Hurst John R.,Brown Jeremy S.,Bradley Judy M.,Tunney Michael M.
Reference30 articles.
1. Boehringer Ingelheim and Mannkind. Payment or honoraria for lectures by Insmed and Unpaid ERS infection group chair. A.D.S.: received grants from AstraZeneca, Pfizer, GSK and Novartis for research into Bronchiectasis and consulting fees from AstraZeneca, Insmed, GSK, Boehringer, 30T and Bayer;M L;J.C.: received funding from Astrazeneca, Boehringer Ingelheim, Chiesi, Glaxosmithkline, Insmed, Novartis, Gilead Sciences, Trudell, Genentech and consulting fees from Astrazeneca Boehringer Ingelheim
2. Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis;R Chandrasekaran;BMC Pulmonary Medicine,2018